Sector
PharmaceuticalsOpen
₹11.57Prev. Close
₹11.35Turnover(Lac.)
₹0.11Day's High
₹11.57Day's Low
₹1152 Week's High
₹18.952 Week's Low
₹9.61Book Value
₹8.4Face Value
₹10Mkt Cap (₹ Cr.)
11.39P/E
0EPS
0Divi. Yield
013 Sep 2024
12:00 AM
AGM
Announcement Date: 13 Sep, 2024
27 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 10.1 | 10.1 | 10.1 | 10.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -1.17 | -1.2 | 1.42 | 1.06 |
Net Worth | 8.93 | 8.9 | 11.52 | 11.16 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0.97 | 1.42 | 0.5 | 0.37 |
yoy growth (%) | -31.43 | 182.32 | 34.45 | 68.17 |
Raw materials | -0.42 | -0.62 | -0.4 | -0.26 |
As % of sales | 43.52 | 43.64 | 80.76 | 70.5 |
Employee costs | -0.19 | -0.32 | -0.24 | -0.15 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.1 | 0.16 | 0.18 | -0.18 |
Depreciation | -0.04 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -0.14 | 0.52 | 2.48 | -0.14 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -31.43 | 182.32 | 34.45 | 68.17 |
Op profit growth | -90.17 | -135.58 | 140.45 | -84.6 |
EBIT growth | -29.37 | -8.16 | -198.91 | -85.56 |
Net profit growth | -42.73 | -7.89 | -198.91 | -85.56 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 22.61 | 35.88 | 45.57 | 65.32 | 55.56 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 22.61 | 35.88 | 45.57 | 65.32 | 55.56 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 1.32 | 0.42 | 7.37 | 7.67 | 0.65 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672.85 | 93.87 | 4,01,372.75 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,931.8 | 83.3 | 1,84,017.51 | 667 | 0.43 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,488.15 | 24.97 | 1,20,199.04 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,323.45 | 59.44 | 1,12,475.6 | 474 | 0.18 | 2,385 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,283.9 | 19.91 | 1,07,151.95 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Sushant Mohan Lal
Independent Director
G Venkateswara Rao
Independent Director
Lakshmi Vijaya Nimmala
Independent Director
Gayathri Raghuram
Non Executive Director
Janaki Rama Ajjarapu
Company Sec. & Compli. Officer
Preeti Singh
4th Flr Plot-94 Sagar Society,
Banjara Hills Road No 2,
Telangana - 500034
Tel: -
Website: http://www.decipherlabs.in
Email: info@decipherlabs.in; cs@decipherlabs.in
12-10-167,
Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.92. The company was prom...
Read More
Reports by Decipher Labs Ltd
What is the Decipher Labs Ltd share price today?
What is the Market Cap of Decipher Labs Ltd?
What is the PE and PB ratio of Decipher Labs Ltd?
What is the 52 Week High and Low of Decipher Labs Ltd?
What is the CAGR of Decipher Labs Ltd?
What is the shareholding pattern of Decipher Labs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.